Global Surgical Site Infection Control Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Surgical site infection control Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global surgical site infection control market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global surgical site infection control market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.1% during 2023-2028.
Surgical site infection control encompasses a set of protocols and practices aimed at averting, addressing, and diminishing the occurrence of infections at the surgical site. These measures involve maintaining sterile or aseptic conditions within the operating room to prevent any form of contamination during surgical procedures. By doing so, it effectively lowers the likelihood of hospital-acquired infections (HAIs) that could potentially lead to complications. Moreover, it contributes to considerable cost savings by reducing the necessity for extra treatments, prolonged hospital stays, and associated legal risks. Additionally, it enhances surgical outcomes, speeds up recovery, and enhances overall patient satisfaction. This approach is extensively employed in healthcare environments to guarantee proper sterilization of surgical instruments, equipment, and supplies, thereby preventing any microbial contamination.
Global Surgical Site Infection Control Market Trends and Drivers:
Furthermore, an increasing awareness among both patients and healthcare practitioners regarding the hazards tied to surgical site infections is shaping a positive trajectory for the market. In addition to this, advancements in infection control offerings like antimicrobial coatings, sterilization technologies, and state-of-the-art wound dressings are propelling market growth. Additionally, the healthcare sector's growing shift towards value-centric care models that emphasize patient well-being and cost efficiency is encouraging the adoption of infection control strategies to minimize postoperative issues. Furthermore, numerous healthcare regulatory bodies are imposing stringent directives and standards on infection control, bolstering the market's expansion.
Global Surgical Site Infection Control Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation
The report segmented the market on the basis of region, product, infection type, surgery type and end user.
Breakup by Product:
Antibiotic Prophylaxis Products
Wound Care Dressings
Surgical Drapes
Surgical Clippers
Antiseptics and Disinfectants
Wound Irrigation Products
Others
Breakup by Infection Type:
Superficial Incisional SSI
Deep Incisional SSI
Organ or Space SSI
Breakup by Surgery Type:
Cesarean Section
Gastric Bypass
Cataract Surgery
Dental Restoration
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Key highlights of the report:
Market Performance (2017-2022)
Market Outlook (2023- 2028)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us: IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Comments